Maxim Group Initiated Xenetic Biosciences Inc. [XBIO]. What else is Wall St. saying?

Related

Share

Xenetic Biosciences Inc. [NASDAQ: XBIO] surged by $0.01 during the normal trading session on Tuesday and reaching a high of $1.4001 during the day while it closed the day at $1.19. Xenetic Biosciences Inc. stock has also gained 10.19% of its value over the past 7 days. However, XBIO stock has inclined by 108.81% in the 3 months of the year. Over the past six months meanwhile, it has lost -7.39% and lost -17.36% year-on date.

The market cap for XBIO stock reached $7.52 million, with 6.23 million shares outstanding and 5.36 million shares in the current float. Compared to the average trading volume of 280.94K shares, XBIO reached a trading volume of 2783452 in the most recent trading day, which is why market watchdogs consider the stock to be active.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Here’s what leading stock market gurus have to say about Xenetic Biosciences Inc. [XBIO]:

Maxim Group have made an estimate for Xenetic Biosciences Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2020.

The Average True Range (ATR) for Xenetic Biosciences Inc. is set at 0.14, with the Price to Sales ratio for XBIO stock in the period of the last 12 months amounting to 101.89. The Price to Book ratio for the last quarter was 0.46, with the Price to Cash per share for the same quarter was set at 1.49.

XBIO stock trade performance evaluation

Xenetic Biosciences Inc. [XBIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.19. With this latest performance, XBIO shares gained by 33.01% in over the last four-week period, additionally sinking by -7.39% over the last 6 months – not to mention a drop of -83.19% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XBIO stock in for the last two-week period is set at 60.71, with the RSI for the last a single of trading hit 61.58, and the three-weeks RSI is set at 59.52 for Xenetic Biosciences Inc. [XBIO]. The present Moving Average for the last 50 days of trading for this stock 0.9418, while it was recorded at 1.1550 for the last single week of trading, and 1.1680 for the last 200 days.

Xenetic Biosciences Inc. [XBIO]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Xenetic Biosciences Inc. [XBIO] shares currently have an operating margin of -56272.41. Xenetic Biosciences Inc.’s Net Margin is presently recorded at -74856.59.

Return on Total Capital for XBIO is now -70.75, given the latest momentum, and Return on Invested Capital for the company is -94.19. Return on Equity for this stock declined to -94.19, with Return on Assets sitting at -71.02. When it comes to the capital structure of this company, Xenetic Biosciences Inc. [XBIO] has a Total Debt to Total Equity ratio set at 0.12. Additionally, XBIO Total Debt to Total Capital is recorded at 0.12, with Total Debt to Total Assets ending up at 0.09.

Reflecting on the efficiency of the workforce at the company, Xenetic Biosciences Inc. [XBIO] managed to generate an average of -$3,193,756 per employee.Xenetic Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.10 and a Current Ratio set at 7.10.

Xenetic Biosciences Inc. [XBIO]: Insider Ownership positions

There are presently around $0 million, or 3.60% of XBIO stock, in the hands of institutional investors. The top three institutional holders of XBIO stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 164,117, which is approximately 35.858% of the company’s market cap and around 14.72% of the total institutional ownership; SABBY MANAGEMENT, LLC, holding 60,523 shares of the stock with an approximate value of $71000.0 in XBIO stocks shares; and ROYAL BANK OF CANADA, currently with $32000.0 in XBIO stock with ownership of nearly 0% of the company’s market capitalization.

Positions in Xenetic Biosciences Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 3 institutional holders increased their position in Xenetic Biosciences Inc. [NASDAQ:XBIO] by around 43,354 shares. Additionally, 5 investors decreased positions by around 329,990 shares, while 3 investors held positions by with 121,300 shares. The mentioned changes placed institutional holdings at 252,044 shares, according to the latest SEC report filing. XBIO stock had 2 new institutional investments in for a total of 37 shares, while 4 institutional investors sold positions of 125,015 shares during the same period.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam